Michael’s Story: Relief from Chronic Pain with Medical Marijuana

The Weedcoin Team

Finding Comfort After Years of Suffering

Chronic pain affects millions, often leaving patients searching for relief beyond traditional medications. At Weedcoin, we’re sharing inspiring stories through the MediWeed Hub with irie vibes to highlight medical marijuana’s potential. In this article, we’ll explore Michael’s journey—a 45-year-old veteran who turned to medical marijuana to manage chronic pain after a back injury. His experience shows how cannabis, particularly balanced strains, can offer relief where other treatments fail—let’s dive into Michael’s story of finding comfort!

Smiling man in military uniform sits on a porch with his cap beside him and a rainbow view.

Michael’s Pain and Treatment Challenges


Michael, a 45-year-old Army veteran, suffered a back injury during service that led to chronic lower back pain. For years, he relied on opioids like oxycodone, prescribed at 40 mg daily, which dulled the pain but caused severe side effects—constipation, drowsiness, and a growing dependency that worried him. By 2023, Michael was experiencing daily pain levels of 7/10, unable to enjoy activities like hiking. Physical therapy and non-opioid medications like ibuprofen offered little relief, and surgery wasn’t an option due to risks. After learning about medical marijuana’s potential for pain management, Michael decided to explore cannabis as an alternative.


Starting with Medical Marijuana


Living in Oregon, a state with a well-established medical cannabis program, Michael consulted a cannabis-specialized doctor who recommended a balanced strain, OG Kush, known for its indica-dominant effects and 1:1 THC:CBD ratio, around 15% each. The doctor suggested starting with a low dose—2.5 mg THC and 2.5 mg CBD via a tincture—to assess his response, gradually increasing to 5 mg of each twice daily. Michael also used a vaporizer for quick relief during flare-ups, inhaling 2.5 mg THC as needed. He ensured his products were lab-tested, confirming consistent cannabinoid levels and no contaminants for safe use.


Pain Relief and Improved Functionality


Within a week, Michael noticed a significant reduction in pain—from 7/10 to 4/10 on average, a 40% improvement. The combination of THC and CBD provided immediate relief through THC’s analgesic effects and sustained anti-inflammatory benefits from CBD. Vaping OG Kush during flare-ups offered relief within 5 minutes, while the tincture provided steady pain control throughout the day. After a month, he reduced his opioid dosage by 50% under his doctor’s supervision, minimizing side effects like constipation. Michael’s functionality improved—he could walk longer distances and return to light hiking, activities he hadn’t enjoyed in years.


Navigating Side Effects and Adjustments


Michael initially experienced mild dizziness and dry mouth, common THC side effects, which he managed by staying hydrated and resting after use. He adjusted his dosing—5 mg THC in the evening caused drowsiness, beneficial for sleep but not ideal during the day, so he lowered his daytime dose to 3 mg THC. Cost was a challenge; his cannabis products cost $100/month, not covered by insurance. Michael offset this by joining a dispensary loyalty program, saving 10% on purchases, and faced skepticism from colleagues but educated them about cannabis’s medical benefits.


Long-Term Benefits and Lifestyle Integration


After six months, Michael’s pain stabilized at 3/10, and he discontinued opioids entirely, a major milestone in reducing dependency risks.
He experimented with other strains, like Bubba Kush, an indica-heavy strain with 18% THC, for nighttime use, finding it enhanced sleep quality. During the day, he stuck with OG Kush for its balanced effects, allowing functionality without sedation. Michael also adopted complementary therapies, such as stretching and acupuncture, to further manage pain, finding that cannabis worked best as part of a holistic approach. He monitored usage to avoid tolerance, taking a 1-week break every three months.


Michael’s Advice for Other Patients


Michael advises patients to work closely with a doctor when transitioning from opioids to cannabis—gradual reduction prevents withdrawal symptoms. He recommends starting with a balanced strain to benefit from both THC and CBD, and using a combination of methods like tinctures and vaping for flexible relief [link to Category 4.1]. Michael stresses the importance of education—understanding how cannabis works gave him confidence in his treatment. He encourages patients to explore various strains and methods to find what works best for their pain management needs.


Admiring Michael’s Journey at Weedcoin


At Weedcoin, we deeply admire Michael’s inspiring journey with chronic pain. His determination to find relief through medical marijuana, reducing his pain by 40% and eliminating opioid dependency, showcases the transformative power of cannabis. Michael’s story of reclaiming his life—returning to hiking and enjoying daily activities—highlights the potential for others to find safer alternatives. His resilience and advocacy for education inspire us, reflecting the hope and healing cannabis can bring to those in need.


Practical Tips



Key Takeaways


  • Michael reduced his chronic pain by 40% using a balanced strain, OG Kush, improving his quality of life. 
  • Cannabis allowed him to cut opioid use by 100%, enhancing functionality and reducing side effects. 
  • Mild side effects like dizziness were manageable with hydration and dose adjustments. 
  • Complementary therapies like stretching enhanced cannabis’s effectiveness for long-term pain management. 
  • Michael’s journey inspires others to explore cannabis as a safer alternative for pain relief.
Glowing cross-section of a human brain with highlighted hippocampus region in warm golden light
By The Weedcoin Team April 14, 2026
A University of Colorado study of 26,000 adults found cannabis users aged 40 to 77 had larger brain volumes and faster processing speeds. Plus a migraine trial.
Empty New Jersey convenience store shelf where hemp products were displayed with dust outlines
By The Weedcoin Team April 13, 2026
A systematic review of 564 fibromyalgia patients found cannabis cut pain scores from 9.0 to 5.0 in six months. NJ hemp shelves go empty today. Seven days to 420.
Texas hemp shop restocking shelves after a judge blocked the statewide smokable hemp ban
By The Weedcoin Team April 12, 2026
A Texas judge blocked the hemp ban. Virginia's governor has until tomorrow. The Medicare CBD hearing lands on 420. And 50,000 people are headed to Denver for it.
Chalk pastel of a shadowy figure behind a frosted glass door with a cannabis leaf shadow
By The Weedcoin Team April 11, 2026
Roger Stone says someone inside the Trump administration is blocking cannabis rescheduling. Spanberger has two days. Massachusetts sent its bill to the governor.
By The Weedcoin Team April 10, 2026
Trump protects medical cannabis in his budget while blocking DC from legalizing. The FBI bans agents from cannabis but allows hemp unless the packaging has a leaf.
Doctor reviewing heart health ECG monitor data with a stethoscope on the desk in a clinic room
By The Weedcoin Team April 9, 2026
A 35-year CARDIA study found no link between cannabis and hypertension. But other major studies show acute cardiovascular risks. Here is the honest full picture.
Young autistic child laughing and building colorful blocks with their father in a sunlit playroom.
By The Weedcoin Team April 8, 2026
A Nature study tracked 82 autistic children on CBD-rich cannabis for six months. Social communication improved on gold-standard assessments. Here is the research.
Empty opioid pill bottles next to cannabis leaves and a recovery journal on a wooden table
By The Weedcoin Team April 7, 2026
New research: states with legal cannabis see a 9-11 point drop in daily opioid use. Over 70% of opioid withdrawal patients report meaningful relief from cannabis.
Elderly man with Parkinson's disease sitting peacefully with his family in a sunlit garden
By The Weedcoin Team April 6, 2026
A new case study shows THC oil reduced Parkinson's motor symptoms by 54.55% in an 83-year-old patient. Here is what the research on cannabis and Parkinson's shows.
Busy cannabis dispensary interior with customers browsing products under warm modern lighting
By The Weedcoin Team April 5, 2026
Legal cannabis revenue projected at $30.5 billion for 2026. Massachusetts fights ballot rollback. DC proposes cannabis-infused drinks. Cannabis skin conditions.
Digital screens displaying red cryptocurrency charts and blockchain data in a darkened trading room
By The Weedcoin Team April 4, 2026
A $280M exploit rattled the Solana ecosystem this week. Cannabis stocks are bleeding under tariff pressure. And CBD is showing real promise for brain injuries.
Elderly woman receiving CBD products from a pharmacist at a pharmacy counter with Medicare forms
By The Weedcoin Team April 3, 2026
A federal judge denied the injunction against Medicare CBD coverage. Trump tariffs are driving up cannabis costs. New Jersey's hemp ban hits in 10 days.
More Posts